These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10761457)

  • 1. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.
    Pirisi M; Scott CA; Avellini C; Toniutto P; Fabris C; Soardo G; Beltrami CA; Bartoli E
    Am J Clin Pathol; 2000 Apr; 113(4):546-54. PubMed ID: 10761457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
    Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
    Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C, iron, and hemochromatosis gene mutations. A meaningful relationship or simple cohabitation?
    Snover DC
    Am J Clin Pathol; 2000 Apr; 113(4):475-8. PubMed ID: 10761447
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?
    Martinelli AL; Franco RF; Villanova MG; Figueiredo JF; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Zago MA
    Acta Haematol; 2000; 102(3):152-6. PubMed ID: 10692680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
    Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.
    Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Lonjon I; Bastie A; Duvoux C; Pawlotsky JM; Zafrani ES; Amselem S; Dhumeaux D
    J Hepatol; 1999 Dec; 31(6):979-84. PubMed ID: 10604569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
    Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
    Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
    Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S
    J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
    Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
    Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iron as comorbid factor in chronic hepatitis C].
    Erhardt A; Hauck K; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):685-91. PubMed ID: 14685669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hemochromatosis genes in chronic hepatitis C.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R; Baldassarre R
    Clin Ter; 2006; 157(1):61-8. PubMed ID: 16669553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course.
    Corengia C; Galimberti S; Bovo G; Vergani A; Arosio C; Mariani R; Redaelli A; Riva A; Cestari C; Pozzi M; Valsecchi MG; Piperno A
    Am J Clin Pathol; 2005 Dec; 124(6):846-53. PubMed ID: 16416733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
    Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
    Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C.
    Lebray P; Zylberberg H; Hue S; Poulet B; Carnot F; Martin S; Chretien Y; Pol S; Caillat-Zuckman S; Bréchot C; Nalpas B
    J Viral Hepat; 2004 Mar; 11(2):175-82. PubMed ID: 14996353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
    Bonkovsky HL; Troy N; McNeal K; Banner BF; Sharma A; Obando J; Mehta S; Koff RS; Liu Q; Hsieh CC
    J Hepatol; 2002 Dec; 37(6):848-54. PubMed ID: 12445428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.